Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.
Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. have?
Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. has 149 citations in the OpenAlex counts ScholarIQ stores.
When was Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. published?
Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. has 2002 year in the ScholarIQ index.
What is the open-access status of Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.?
Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. has closed oa status in the ScholarIQ index.
What is the PMID of Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.?
The PMID for Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. is on the source record.
What is the OpenAlex record for Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.?
The OpenAlex for Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. is on the source record.